DOCSLIB.ORG

Ryan White Part a Formulary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ryan White Part a Formulary Ryan White Part A Formulary Updated ƵŐƵƐƚ 2019 Ryan White Part A Pharmacy Formulary - Updated 8/19/19 Tier 1: In order to access Tier 1, clients must qualify for the Ryan White Part A Program based on eligiblity requirements. Generic Name Brand Name Drug Classification Tier Acetazolamide Diamox CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Acetic Acid Vosol Otic Anti-Infectives 1 Acetic Acid/HC Vosol HC Otic Anti-Infectives 1 Al, Mg, Simethicone Mylanta DS Gastrointest/Antacid 1 Albuterol tab Ventolin Respiratory, Cough & Cold Allergy/BetaAgonist Oral 1 Allopurinol Zyloprim Misc/Other 1 Alpha-Linoleic Acid Omega 3 Antihyperlipidemic Agents- Dietary Source 1 Amiiodarone Cordarone Cardiac & Anti-Hypertensive/Antiarrythmic 1 Ammonium lact Lac-Hydrin Topical, Dermatology, Rectal, Vaginal/Topical: Misc/Other 1 Amoxicillin Amoxil Antiinfectives/Antiviral/Antibacterial 1 Amoxicillin/Clavulanate Potassium Augmentin Antiinfectives/Antiviral/Antibacterial 1 Artificial tears Tearisol Ophthalmic/Misc/Other 1 Aspirin Clopidogrel *Aspirin may only be dispensed with Clopidogrel Plavix Cardiac & Anti-Hypertensive/Antiplatelet 1 Baclofen Lioresal CNS, Anxiety, Psych, Neuro, & Autonomic/Muscle Relaxant 1 Benzonatate Tessalon Antitussives 1 Benztropine Cogentin CNS, Anxiety, Psych, Neuro, & Autonomic/Misc 1 Betamethasone Diprosone Topical, Dermatology, Rectal, Vaginal/Corticosteroid 1 Betaxolol Betoptic S Ophthalmic/Betablocker 1 Bimatoprost Lumigan Ophthalmic/Glaucoma 1 B-Plex with C Antioxidant Vitamins & Nutritional/Vitamins 1 Brimonide Alphagan Ophthalmic/Glaucoma 1 Brinzolamide Azopt Ophthalmic/Glaucoma 1 Budesonide Rhinocort Nasal 1 Bumetanide Bumex Cardiac & Anti-Hypertensive/Diuretic 1 Buspirone Buspar CNS, Anxiety, Psych, Neuro, & Autonomic/Antidepressant 1 Butalbitol/Acetaminophen/Caffeine Fioricet CNS, Anxiety, Psych, Neuro, & Autonomic/Analgesic 1 Calcium Acetate Calcium Minerals, Electrolytes/Phosphate Binders 1 Carbamazepine Tegretol CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Carbamide Peroxide Debrox Otic 1 Carbidopa/Levodopa Sinemet CNS, Anxiety, Psych, Neuro, & Autonomic/Antiparkinson 1 Carbinoxamine/Pseudoephedrine Cardec, Cardec DM, Cardec S Respiratory, Cough & Cold Allergy/Antihist/Decongestant 1 Carisoprodol Soma CNS, Anxiety, Psych, Neuro, & Autonomic/Muscle Relaxant 1 Carvedilol Coreg Cardiac & Anti-Hypertensive/AlphaBeta Blocker 1 Cefdinir Omnicef Antiinfectives/Antiviral/Antibacterial 1 Ceftriaxone INJ Rocephin Antiinfectives/Antiviral/Antibacterial 1 Cefuroxime Ceftin Antiinfectives/Antiviral/Antibacterial 1 Generic Name Brand Name Drug Classification Tier Celebrex Celecoxib CNS, Anxiety, Psych, Neuro, & Autonomic/Analgesic 1 Cephalexin Keflex Antiinfectives/Antiviral/Antibacterial 1 Chlorhexidine 12% Solution Peridex Oral Rinse Misc/Other 1 Chlorpromazine Thorazine CNS, Anxiety, Psych, Neuro, & Autonomic/Antipsychotic 1 Ciprofloxacin Ciloxin Ophthalmic/Antibiotic 1 Ciprofloxacin Cipro Antiinfectives/Antiviral/Antibacterial 1 Ciprofloxacin/Hydrocortisone Cipro HC Otic Steroids 1 Clindamycin Cleocin Antiinfectives/Antiviral/Antibacterial 1 Clindamycin Cleocin Vag Topical, Dermatology, Rectal, Vaginal/Antibacterial 1 Clobetasol Temovate Topical, Dermatology, Rectal, Vaginal/Corticosteroid 1 Clonazepam Klonopin CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Clonidine Catapres Cardiac & Anti-Hypertensive/Alpha Blockers 1 Colchicine Colchicine Misc/Other 1 Cyclobenzaprine Flexeril CNS, Anxiety, Psych, Neuro, & Autonomic/Muscle Relaxant 1 Cycloserine Seromycin Antiinfectives/Antitubercular 1 Cyproheptadine Periactin Wasting 1 Danocrine Danazol Misc/Other 1 Dexamethasone Decadron Antiinfectives/Antiinflammatory 1 Dexamethasone/Neomycin/ Polymyxin B Dexacidin Ophthalmic/Antibiotic 1 Diazepam Valium CNS, Anxiety, Psych, Neuro, & Autonomic/Antianxiety/Hypnotic 1 Diclofenac Topical Voltaren (gel) Topical Non-Steroidal Anti-Inflammatories 1 Dicyclomine Bentyl Gastrointest/Antispasmotic 1 Diflorasone Psorcon Topical, Dermatology, Rectal, Vaginal/Corticosteroid 1 Docusate sodium Colace Gastrointest/Laxative 1 Docusate/Casanth Peri-Colace Gastrointest/Laxative 1 Dorzolamide+Timolol Cosopt Ophthalmic/Glaucoma 1 Doxycycline Vibramycin Antiinfectives/Antiviral/Antibacterial 1 Dutasteride Avodart 5-Alpha-Reductase Inhibitors/BPH 1 Erythomycin / Benzoyl perox Benzagel Topical, Dermatology, Rectal, Vaginal/Antibacterial 1 Erythromycin E-Mycin Ophthalmic/Antibiotic 1 Erythromycin base Ery-tab Antiinfectives/Antiviral/Antibacterial 1 Estrogen Conjugated Premarin GYN/OB 1 Ethinyl Estradiol/Norgestimate Ortho-Tricyclen 28 GYN/OB 1 Ethinyl Estradiol/Norgestrel Lo-Ovral 28 GYN/OB 1 Ethosuximide Zarontin CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Ferrous Sulfate/Fumerate Feosol Vitamins & Nutritional/Vitamins 1 Fiberlax Fibercon Gastrointest/Laxative 1 Fluocinolone Dermasmoothe Topical, Dermatology, Rectal, Vaginal/Corticosteroid 1 Generic Name Brand Name Drug Classification Tier Fluorometholone FML Ophthalmic/Steroid 1 Formoterol/Mometasone Dulera Bronchodilator Combinations 1 Guaifen/Codeine/Pseudoephedrine Robitussin DAC Respiratory, Cough & Cold Allergy/Antitussive 1 Guaifen/Dextromethorphan Robitussin DM Respiratory, Cough & Cold Allergy/Antitussive 1 Guaifenesin Robitussin Respiratory, Cough & Cold Allergy/Antitussive 1 Guaifenesin/Codeine Robitussin AC Respiratory, Cough & Cold Allergy/Antitussive 1 Haloperidol Haldol CNS, Anxiety, Psych, Neuro, & Autonomic/Antipsychotic 1 HCTZ HydroDiuril Cardiac & Anti-Hypertensive/Diuretic 1 HCTZ/Triamterene Dyazide Cardiac & Anti-Hypertensive/Diuretic 1 Hydrocodone/Acetaminophen Vicodin,VicodinES CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic 1 Hydrocortisone Cream Hytone Topical, Dermatology, Rectal, Vaginal/Corticosteroid 1 Hydrocortisone Suppository Anusol-HC Topical, Dermatology, Rectal, Vaginal/Corticosteroid 1 Hydroxyzine Vistaril,Atarx CNS, Anxiety, Psych, Neuro, & Autonomic/Antianxiety/Hypnotic 1 Irbesartan Avapro Cardiac & Anti-Hypertensive/Angiotensin Receptor Blocker (ARB) 1 Isoniazid/Rifampin Rifamate Antiinfectives/Antitubercular 1 Isosorbide Mononitrate Imdur Cardiac & Anti-Hypertensive/Nitrates 1 Labetalol Normodyne Cardiac & Anti-Hypertensive/Beta Blockers 1 Lansoprazole Prevacid Gastrointest/PPI 1 Latanoprost Xalatan Ophthalmic/Glaucoma 1 Leuprolide Lupron Gonadotropin Releasing Hormones 1 Lindane Kwell Topical, Dermatology, Rectal, Vaginal/Topical: Misc/Other 1 Lithium Carb Lithonate CNS, Anxiety, Psych, Neuro, & Autonomic/Antidepressant 1 Lodoxamide Alomide Ophthalmic/Misc/Other 1 Loperamide Paregoric Imodium Gastrointest/Antidiarrheal 1 Lorazepam Ativan CNS, Anxiety, Psych, Neuro, & Autonomic/Antianxiety/Hypnotic 1 MAGIC Mouthwash MAGIC Mouthwash Misc/Other 1 Methadone Methadone CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic 1 Methocarbamol Robaxin Skeletal Muscle Relaxants 1 Methyprednisolone Medrol dosepak Antiinfectives/Antiinflammatory 1 Montileukast Singulair Respiratory, Cough & Cold Allergy/Other 1 MSContin, MSIR Morphine CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic 1 Mupirocin Bactroban Topical Antibiotic 1 Naphazoline Vasocon Ophthalmic/Misc/Other 1 Neo/Gramic/Poly Neosporin Topical, Dermatology, Rectal, Vaginal/Antibacterial 1 Neo/Poly/Bacit Neosporin Ophthalmic/Antibiotic 1 Neomycin / HC Cortisporin Otic 1 Neurontin Gabapentin CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Nitrofurantoin Macrodantin Antiinfectives/Antiviral/Antibacterial 1 Generic Name Brand Name Drug Classification Tier Nystatin Mycostatin Topical, Dermatology, Rectal, Vaginal/Antifungal 1 Nystatin/Triamcin Mycolog Topical, Dermatology, Rectal, Vaginal/Antifungal 1 Olopatadine Ophthalmic Pataday Ophthalmic Antihistamines and Decongestants 1 Oxybutinin Ditropan Misc/Other 1 Oxycodone/Acet Percocet CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic 1 Oxycodone/ASA Percodan CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic 1 Pancrealipase Ultrace MT Gastrointest/Digestive Enzyme 1 Paromomycin Humatin Antiinfectives/Other 1 Pen Needles Pen Needles *for Lantus/Levemir Medication Administration 1 Penicililn VK PenVK Antiinfectives/Antiviral/Antibacterial 1 Penicillin Benzath Bicillin LA Antiinfectives/Antiviral/Antibacterial 1 Permethrin Elimite Topical, Dermatology, Rectal, Vaginal/Topical: Misc/Other 1 Perphenazine Trilafon CNS, Anxiety, Psych, Neuro, & Autonomic/Antipsychotic 1 Phenazopyridine Pyridium Misc/Other 1 Phenobarbital Phenobarbital CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Phenytoin Dilantin CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant 1 Pilocarpine Pilocar Ophthalmic/Miotic 1 Podophilox Condylox Topical, Dermatology, Rectal, Vaginal/Topical: Misc/Other 1 Polyethylene Glycol Electrolyte GoLytely/Colyte Gastrointest/Misc/Other 1 Pramipexole Mirapex Dopaminergic Antiparkinaonism Agents 1 Prednisolone Pred Forte Ophthalmic/Steroid 1 Prednisone Deltasone Antiinfectives/Antiinflammatory 1 Promethazine Suppos Promethazine Suppos Gastrointest/Antiemetic 1 Propranolol Inderal Cardiac & Anti-Hypertensive/Beta Blockers 1 Pseudoephedrine Sudafed Respiratory, Cough & Cold Allergy/Antihist/Decongestant 1 Rivaroxaban Xarelto Anticoagulant/Factor Xa Inhibitors 1 Salmeterol Discus Serevent Respiratory, Cough & Cold Allergy/BetaAgonist Inhaled 1 Selenium Selsun Topical, Dermatology, Rectal, Vaginal/Topical: Misc/Other 1 Simethicone Mylicon Gastrointest/Antiflatulant 1 Sodium Chloride Ocean Nasal Nasal 1 Sodium Chloride for Irrigation Normal Saline Misc/Other 1 Spironolactone
Load more

Recommended publications
  • MSM Cross Reference Antihistamine Decongestant 20100701 Final Posted
    MISSISSIPPI DIVISION OF MEDICAID Antihistamine/Decongestant Product and Active Ingredient Cross-Reference List The agents listed below are the antihistamine/decongestant drug products listed in the Mississippi Medicaid Preferred Drug List (PDL). This is a cross-reference between the drug product name and its active ingredients to reference the antihistamine/decongestant portion of the PDL. For more information concerning the PDL, including non- preferred agents, the OTC formulary, and other specifics, please visit our website at www.medicaid.ms.gov. List Effective 07/16/10 Therapeutic Class Active Ingredients Preferred Non-Preferred ANTIHISTAMINES - 1ST GENERATION BROMPHENIRAMINE MALEATE BPM BROMAX BROMPHENIRAMINE MALEATE J-TAN PD BROMSPIRO LODRANE 24 LOHIST 12HR VAZOL BROMPHENIRAMINE TANNATE BROMPHENIRAMINE TANNATE J-TAN P-TEX BROMPHENIRAMINE/DIPHENHYDRAM ALA-HIST CARBINOXAMINE MALEATE CARBINOXAMINE MALEATE PALGIC CHLORPHENIRAMINE MALEATE CHLORPHENIRAMINE MALEATE CPM 12 CHLORPHENIRAMINE TANNATE ED CHLORPED ED-CHLOR-TAN MYCI CHLOR-TAN MYCI CHLORPED PEDIAPHYL TANAHIST-PD CLEMASTINE FUMARATE CLEMASTINE FUMARATE CYPROHEPTADINE HCL CYPROHEPTADINE HCL DEXCHLORPHENIRAMINE MALEATE DEXCHLORPHENIRAMINE MALEATE DIPHENHYDRAMINE HCL ALLERGY MEDICINE ALLERGY RELIEF BANOPHEN BENADRYL BENADRYL ALLERGY CHILDREN'S ALLERGY CHILDREN'S COLD & ALLERGY COMPLETE ALLERGY DIPHEDRYL DIPHENDRYL DIPHENHIST DIPHENHYDRAMINE HCL DYTUSS GENAHIST HYDRAMINE MEDI-PHEDRYL PHARBEDRYL Q-DRYL QUENALIN SILADRYL SILPHEN DIPHENHYDRAMINE TANNATE DIPHENMAX DOXYLAMINE SUCCINATE
    [Show full text]
  • 2-Bromopyridine Safety Data Sheet Jubilant Ingrevia Limited
    2-Bromopyridine Safety Data Sheet According to the federal final rule of hazard communication revised on 2012 (HazCom 2012) Date of Compilation : July 03 ’ 2019 Date of Revision : February 09 ’ 2021 Revision due date : January 2024 Revision Number : 01 Version Name : 0034Gj Ghs01 Div.3 sds 2-Bromopyridine Supersedes date : July 03 ’ 2019 Supersedes version : 0034Gj Ghs00 Div.3 sds 2-Bromopyridine Jubilant Ingrevia Limited Page 1 of 9 2-Bromopyridine Safety Data Sheet According to the federal final rule of hazard communication revised on 2012 (HazCom 2012) SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier PRODUCT NAME : 2-Bromopyridine CAS RN : 109-04-6 EC# : 203-641-6 SYNONYMS : 2-Pyridyl bromide, Pyridine, 2-bromo-, beta-Bromopyridine, o-Bromopyridine SYSTEMATIC NAME : 2-Bromopyridine, -Pyridine, 2-bromo- MOLECULAR FORMULA : C5H4BrN STRUCTURAL FORMULA N Br 1.2. Relevant identified uses of the substance or mixture and uses advised against 1.2.1. Relevant identified uses 2-Bromopyridine is used as an intermediate in the pharmaceutical industry for the manufacture of Atazanavir (an antiretroviral drug), Carbinoxamine, Chloropyramine, triprolidine (antihistamine drugs), Disopyramide Phosphate (an antiarrythmic drug), Mefloquine (antimalarial drug), Pipradrol (mild CNS stimulant) etc. Uses advised against: None 1.3. Details of the supplier of the safety data sheet Jubilant Ingrevia Limited REGISTERED & FACTORY OFFICE: Jubilant Ingrevia Limited Bhartiagram, Gajraula , District: Amroha, Uttar Pradesh-244223, India PHONE NO: +91-5924-252353 to 252360 Contact Department-Safety: Ext. 7424 , FAX NO : +91-5924-252352 HEAD OFFICE: Jubilant Ingrevia Limited, Plot 1-A, Sector 16-A,Institutional Area, Noida, Uttar Pradesh, 201301 - India T +91-120-4361000 - F +91-120-4234881 / 84 / 85 / 87 / 95 / 96 [email protected] -www.jubilantingrevia.com 1.4.
    [Show full text]
  • Medication Instructions for Allergy Patients
    MEDICATION INSTRUCTIONS FOR ALLERGY PATIENTS Drugs which contain antihistamine or have antihistaminic effects can result in negative reactions to skin testing. As a result, it may not be possible to properly interpret skin test results, and testing may have to be repeated at a later date. While this list is extensive, it is NOT all inclusive (particularly of the various brand names). Discontinue ALL antihistamines including the following medications seven (7) days prior to skin testing (unless longer time specified): Antihistamines – Generic name (Brand name(s)): Cetirizine (Zyrtec, Zyrtec-D) Hydroxyzine (Vistaril, Atarax) Desloratadine (Clarinex) Levocetirizine (Xyzal) Fexofenadine (Allegra, Allegra-D) Loratadine (Claritin, Claritin-D, Alavert) Diphenhydramine (Aleve PM, Benadryl, Bayer P.M., Benylin, Contac P.M., Doans P.M, Excedrin PM, Legatrin P.M.. Nytol, Tylenol Nighttime, Unisom, Zzzquil) Chlorpheniramine (Aller-Chlor, Allerest, Alka Seltzer Plus, Chlor-Trimeton, Comtrex, Contac, Co-Pyronil, Coricidin, CTM, Deconamine, Dristan, Dura-tap, Naldecon, Ornade Spansules, Rondec, Sinutab, Teldrin, Triaminic, Triaminicin, Tylenol Allergy) Azatadine (Optimine, Trinalin) Doxylamine (Nyquil) Brompheniramine (Bromfed, Dimetane, Dimetapp) Meclizine (Antivert) Carbinoxamine (Clistin, Rondec) Pheniramine Clemastine (Tavist) Phenyltoloxamine (Nadecon) Cyclizine (Marezine) Promethazine (Phenergan) Cyprohepatidine (Periactin) (9 days) Pyrilamine (Mepyramine) Dexbrompheniramine (Drixoral) Quinacrine (Atabrine) Dexchlorpheniramine (Extendryl, Polaramine)
    [Show full text]
  • Antihistamine Therapy in Allergic Rhinitis
    CLINICAL REVIEW Antihistamine Therapy in Allergic Rhinitis Paul R. Tarnasky, MD, and Paul P. Van Arsdel, Jr, MD Seattle, Washington Allergic rhinitis is a common disorder that is associated with a high incidence of mor­ bidity and considerable costs. The symptoms of allergic rhinitis are primarily depen­ dent upon the tissue effects of histamine. Antihistamines are the mainstay of therapy for allergic rhinitis. Recently, a second generation of antihistamines has become available. These agents lack the adverse effect of sedation, which is commonly associated with older antihistamines. Current practice of antihistamine therapy in allergic rhinitis often involves random selection among the various agents. Based upon the available clinical trials, chlorpheniramine appears to be the most reasonable initial antihistaminic agent. A nonsedating antihis­ tamine should be used initially if a patient is involved in activities where drowsiness is dangerous. In this comprehensive review of allergic rhinitis and its treatment, the cur­ rent as well as future options in antihistamine pharmacotherapy are emphasized. J Fam Pract 1990; 30:71-80. llergic rhinitis is a common condition afflicting some­ defined by the period of exposure to those agents to which A where between 15 and 30 million people in the United a patient is sensitive. Allergens in seasonal allergic rhinitis States.1-3 The prevalence of disease among adolescents is consist of pollens from nonflowering plants such as trees, estimated to be 20% to 30%. Two thirds of the adult grasses, and weeds. These pollens generally create symp­ allergic rhinitis patients are under 30 years of age.4-6 Con­ toms in early spring, late spring through early summer, sequently, considerable costs are incurred in days lost and fall, respectively.
    [Show full text]
  • Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014
    Supplementary Online Content Hales CM, Kit BK, Gu Q, Ogden CL. Trends in prescription medication use among children and adolescents— United States, 1999-2014. JAMA. doi:10.1001/jama.2018.5690 eTable. Classification of Prescription Medications Reported by NHANES Participants Aged 0-19 Years From 1999- 2000 to 2013-2014 by Therapeutic Class This supplementary material was provided by the authors to give readers additional informtion about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 eTable. Classification of Prescription Medications Reported by NHANES Participants Aged 0-19 Years From 1999- 2000 to 2013-2014 by Therapeutic Class Therapeutic classes are based on the Lexicon Plus prescription medication database and only those classes reported in the manuscript are listed. ADHD Medications Antiadrenergic Agents, Centrally Acting Clonidine Guanfacine CNS Stimulants Amphetamines Amphetamine Amphetamine; Dextroamphetamine Dextroamphetamine Lisdexamfetamine Methylphenidate or Dexmethylphenidate Dexmethylphenidate Methylphenidate Other CNS Stimulant Pemoline Selective Norepinephrine Reuptake Inhibitor Atomoxetine Antibiotics Cephalosporins Cefadroxil Cephalexin Cefaclor Cefprozil Cefuroxime Loracarbef Cefdinir Cefditoren Cefixime Cefpodoxime Ceftibuten Ceftriaxone Glycopeptide Antibiotics Vancomycin H. Pylori Eradication Agents Amoxicillin; Clarithromycin; Lansoprazole Lincomycin Derivatives Clindamycin Macrolide Derivatives Telithromycin Azithromycin Clarithromycin
    [Show full text]
  • Medication Guide for a Safe Recovery
    Medication Guide For A Safe Recovery A guide to maintaining sobriety while receiving treatment for other health problems. Revision 1.0 -April 2008 Table of Contents Introduction..................................................................................2 How to Use this Guide..................................................................3 Class A Drugs (Absolutely Avoid)................................................4 Class B Drugs................................................................................8 (With Addiction Medicine Specialist/Doctor Approval Only) Class C Drugs (Generally Safe to Take).....................................12 Alcohol-Free Products..................................................................16 Incidental Exposure Index...........................................................22 www.talbottcampus.com Introduction From the Talbott Recovery Campus Welcome to the Talbott Recovery Campus guide for a safe and sustained recovery. This document was developed through a collaborative effort between some of the best minds in addiction care today and will help you make wise decisions, ensuring that medications you may be prescribed and incidental exposure to alcohol do not threaten your hard won recovery. This guide is divided into three sections and is based on the drug classification system developed nearly 20 years ago by Dr. Paul Earley and recently expanded on by Bruce Merkin, M.D., Renee Enstrom, Nicholas Link and the staff at Glenbeigh hospital. Part one provides a way of categorizing medications
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2006) – Supplement 1 (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2006) – Supplement 1 (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABACAVIR 136470-78-5 ACEXAMIC ACID 57-08-9 ABAFUNGIN 129639-79-8 ACICLOVIR 59277-89-3 ABAMECTIN 65195-55-3 ACIFRAN 72420-38-3 ABANOQUIL 90402-40-7 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABCIXIMAB 143653-53-6 ACITEMATE 101197-99-3 ABECARNIL 111841-85-1 ACITRETIN 55079-83-9 ABIRATERONE 154229-19-3 ACIVICIN 42228-92-2 ABITESARTAN 137882-98-5 ACLANTATE 39633-62-0 ABLUKAST 96566-25-5 ACLARUBICIN 57576-44-0 ABUNIDAZOLE 91017-58-2 ACLATONIUM NAPADISILATE 55077-30-0 ACADESINE 2627-69-2 ACODAZOLE 79152-85-5 ACAMPROSATE 77337-76-9 ACONIAZIDE 13410-86-1 ACAPRAZINE 55485-20-6 ACOXATRINE 748-44-7 ACARBOSE 56180-94-0 ACREOZAST 123548-56-1 ACEBROCHOL 514-50-1 ACRIDOREX 47487-22-9 ACEBURIC
    [Show full text]
  • Proposed Changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (Effective from 01.01.2022)
    Proposed changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (effective from 01.01.2022) SUBSTANCE NAME CURRENT PROPOSED COMMENT STATUS EPSL CATEGORY ACETYLCHOLINESTERASE INHIBITOR Used in the treatment of Edrophonium Controlled Banned myasthenia gravis and Medication Substance has no legitimate use in the treatment of sports horses Used to increase Huperzine A Unlisted Banned alertness and treat Substance myasthenia gravis. The substance has no legitimate use in the treatment of sports horses. AMIDES Palmitoylethanolamid Banned Controlled Used in the treatment of Substance Medication joint pain ANGIOTENSIN CONVERTING ENZYME INHIBITORS Enalapril Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse Enalaprilat Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse Lisinopril Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse Moexipril Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse 1 Perindoprilat Controlled Banned The substance carries a Medication Substance high risk of abuse and has no legitimate use in the sports horse ANTIHISTAMINES Antazoline Controlled Banned The substance has no Medication Substance legitimate use in the sports horse Azatadine Controlled Banned The substance has Medication Substance sedative effects
    [Show full text]
  • Ryan White Part a Formulary
    Ryan White Part A Formulary Updated ƵŐƵƐƚ 2019 Ryan White Part A Pharmacy Formulary - Updated 8/19/19 Tier 1: In order to access Tier 1, clients must qualify for the Ryan White Part A Program based on eligiblity requirements. Drug Classification Brand Name Generic Name Tier 5-Alpha-Reductase Inhibitors/BPH Avodart Dutasteride 1 Anticoagulant/Factor Xa Inhibitors Xarelto Rivaroxaban 1 Antihyperlipidemic Agents- Dietary Source Omega 3 Alpha-Linoleic Acid 1 Antiinfectives/Antifungal Lamisil Terbinafine 1 Antiinfectives/Antiinflammatory Decadron Dexamethasone 1 Antiinfectives/Antiinflammatory Deltasone Prednisone 1 Antiinfectives/Antiinflammatory Medrol dosepak Methyprednisolone 1 Antiinfectives/Antitubercular Rifamate Isoniazid/Rifampin 1 Antiinfectives/Antitubercular Seromycin Cycloserine 1 Antiinfectives/Antiviral/Antibacterial Achromycin Tetracycline 1 Antiinfectives/Antiviral/Antibacterial Amoxil Amoxicillin 1 Antiinfectives/Antiviral/Antibacterial Augmentin Amoxicillin/Clavulanate Potassium 1 Antiinfectives/Antiviral/Antibacterial Bicillin LA Penicillin Benzath 1 Antiinfectives/Antiviral/Antibacterial Ceftin Cefuroxime 1 Antiinfectives/Antiviral/Antibacterial Cipro Ciprofloxacin 1 Antiinfectives/Antiviral/Antibacterial Cleocin Clindamycin 1 Antiinfectives/Antiviral/Antibacterial Ery-tab Erythromycin base 1 Antiinfectives/Antiviral/Antibacterial Keflex Cephalexin 1 Antiinfectives/Antiviral/Antibacterial Macrodantin Nitrofurantoin 1 Antiinfectives/Antiviral/Antibacterial Omnicef Cefdinir 1 Antiinfectives/Antiviral/Antibacterial PenVK Penicililn
    [Show full text]
  • Carbinoxamine
    Cigna National Formulary Coverage Policy Step Therapy Carbinoxamine Table of Contents Product Identifier(s) National Formulary Medical Necessity ................ 1 61867 Conditions Not Covered....................................... 2 Background .......................................................... 2 References .......................................................... 3 Revision History ................................................... 3 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage Policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a Coverage Policy. In the event of a conflict, a customer’s benefit plan document always supersedes the information in the Coverage Policies. In the absence of a controlling federal or state coverage mandate, benefits are ultimately determined by the terms of the applicable benefit plan document. Coverage determinations in each specific instance require consideration of 1) the terms of the applicable benefit plan document in effect on the date of service; 2) any applicable laws/regulations; 3) any relevant collateral source materials including Coverage Policies and; 4) the specific facts of the particular situation. Coverage Policies relate exclusively to the administration of health benefit plans.
    [Show full text]
  • Management of Allergy Symptoms
    MANAGEMENT OF ALLERGY SYMPTOMS The “common cold”, which can be caused by many different viral infections, is usually self- limited, going away in several days to a couple of weeks. The mucous lining of the nose swells, causing congestion, runny nose (often profuse), postnasal drip, and cough. There is often an accompanying fever, sometimes chills, fatigue, muscle and body aches, headaches, and general ill feeling. Rest, fluids, mild decongests to reduce swelling and improve drainage, and most importantly, some “time”, occasionally up to 4 weeks, is all that is needed. “Allergies” are to blame for most of the seasonal and/or year-round “colds” that seem to happen one after another. It is only with continued repeated exposure that you develop allergies. This can occur at any age and, with any environmental changes. There is often a family history of allergies, asthma and/or eczema that predisposes to this increased biological responsiveness. “Allergens,” the offending agents, cause a release of a chemical substances, HISTAMINE, from you mast cells. Your mast cells are white blood cells that are part of you immune system involved in keeping watch for foreign invaders, and reacting to them. When they respond too easily, too quickly, you have allergies. Histamine causes a variety of symptoms, sometimes only one, sometimes several at once, including: itching, sneezing, eye irritation, nasal and sinus congestion (often with sinus pain), and headaches may develop. Mucous production increases and may drip down the back of your throat (postnasal drip) causing sore throats, voice changes (laryngitis), hacking coughs, loss of taste, smell and itchy roof of the mouth.
    [Show full text]
  • West Essex CCG Anticholinergic Side-Effects and Prescribing Guidance
    Anticholinergic side-effects and prescribing guidance . Anticholinergic (antimuscarinic) medications: associated with increased risks of impaired cognition and falls in patients over the age of 65 years. Recent research also points to a link to mortality increasing with the number and potency of anticholinergic agents prescribed. Anticholinergic Syndrome: is a state of confusion with characteristic features related to dysfunction of the autonomic parasympathetic (cholinergic) nervous system. Symptoms classified into systemic and CNS manifestations: o Systemic (peripheral) symptoms: Blurred vision, photophobia, non-reactive mydriasis, loss of accommodation response, flushed and dry skin, dry mouth, tachycardia, hypertension and fever. Gastrointestinal and urinary motility are frequently reduced o CNS symptoms: Delirium, agitation, disorientation, and visual hallucinations. Ataxia, choreoathetosis, myoclonus and seizures may also occur without peripheral symptoms. Medication Issues: several commonly prescribed medications that may not be thought of as anticholinergic have significant anticholinergic effects, which when taken with known anticholinergic medication can increase the risk of adverse effects. Many medication groups e.g. antihistamines, tricyclic antidepressants, drugs for asthma and COPD, cold preparations, hyoscine have varying degrees of anticholinergic activity and have the potential to cause Anticholinergic Syndrome . Clinicians should be aware of the risk for chronic anticholinergic toxicity and the fact that not all the symptoms may manifest in patients and if they do suffer some symptoms they could be wrongly attributed to another diagnosis Evidence . A study of patients over 65 found that 20% of participants who scored four or more had died by the end of the two year study period compared with 7% of patients with a score of zero.
    [Show full text]